Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The most studied preclinical doses are 10 g/kg and 10 ng/kg administered subcutaneously, intraperitoneally, or orally
Although there is a general consensus that endothelial dysfunction is a reliable indicator of the advancement of atherosclerosis and potential cardiovascular events, additional research is needed to fully understand its impact on hypertension and platelet hyperactivity
The enzyme of the second step, GSH2, localizes predominantly in the cytosol but also in the plastids (Wachter et al
Most common include: Mild irritation at the injection site Nausea, bloating, or stomach cramps Mild sulfur (rotten egg) taste in the mouth Rare but serious: Allergic reactions (hives, swelling of face/lips/tongue/throat, difficulty breathing)
Study Design Highlights Study type: In vitro (Caco-2 cell model) and preclinical animal model Compound: Astragaloside II (key bioactive from Astragalus membranaceus) Outcomes: Cellular activity and growth, L-arginine uptake, transport pathway activity, protein signaling, intestinal structure markers Key Findings (What the Study Showed) Astragaloside II associated with increased cellular activity and growth in intestinal cell models, suggesting support for normal cellular function Increased uptake of L-arginine and supported activity of transport pathways involved in nutrient absorption Influenced signaling pathways involved in protein metabolism and cellular activity, indicating support for normal cellular processes Animal models: Improvements in markers related to intestinal structure and overall physiological condition Why This Study Matters This study identifies Astragaloside II as a key bioactive compound within Astragalus membranaceus that contributes to AstraGin's overall function specifically supporting amino acid uptake and cellular activity at the intestinal level
Zhang, Y., Koppula, P
